F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works

https://www.nytimes.com/2021/06/07/health/aduhelm-fda-alzheimers-drug.html

Aducanumab, or Aduhelm, is the first new Alzheimer's treatment in 18 years and the first to attack the disease process.